AXSOME THERAPEUTICS I

Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder

01 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire

Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients

25 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy

25 мар 2024 06:30:00 Источник Nasdaq GlobeNewswire

Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder

19 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire

Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference

05 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire

Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference

27 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

20 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

12 фев 2024 09:47:31 Источник NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

09 фев 2024 09:54:59 Источник NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

08 фев 2024 13:42:43 Источник NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

06 фев 2024 11:00:35 Источник NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

24 янв 2024 10:38:35 Источник NetDania Notify

Axsome Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20

23 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

10 янв 2024 09:46:51 Источник NetDania Notify

Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones

04 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire

Axsome Therapeutics Presents New Data and Post-Hoc Analyses of Auvelity® in Patients with Major Depressive Disorder at the American College of Neuropsychopharmacology (ACNP) 2023 Annual Meeting

11 дек 2023 07:00:00 Источник Nasdaq GlobeNewswire

Axsome Therapeutics Hosts Solriamfetol Virtual Investor Event with Expert Thought Leaders Today

07 дек 2023 07:00:00 Источник Nasdaq GlobeNewswire

Axsome Therapeutics to Host Solriamfetol Virtual Investor Event on December 7

22 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

Axsome Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference

21 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

Axsome Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

06 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire